021-51111890
购物车（）
sales@molnova.cn
MW01-2-151SRM
CAS No. 886208-65-7
MW01-2-151SRM ( —— )
产品货号. M34659 CAS No. 886208-65-7
MW01-2-151SRM is a novel small molecule inhibitor of microglia activation that crosses the blood-brain barrier, has anti-neuroinflammatory effects, attenuates the up-regulation of glial cytokines in models of neuroinflammation, and can be used in studies of traumatic brain injury, Alzheimer's disease, and alginate toxicity.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥4674 | 有现货 |
|
| 10MG | ￥6774 | 有现货 |
|
| 25MG | ￥9858 | 有现货 |
|
| 50MG | ￥12834 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称MW01-2-151SRM
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述MW01-2-151SRM is a novel small molecule inhibitor of microglia activation that crosses the blood-brain barrier, has anti-neuroinflammatory effects, attenuates the up-regulation of glial cytokines in models of neuroinflammation, and can be used in studies of traumatic brain injury, Alzheimer's disease, and alginate toxicity.
-
产品描述MW01-2-151SRM is a novel small molecule inhibitor of microglia activation that crosses the blood-brain barrier, has anti-neuroinflammatory effects, attenuates the up-regulation of glial cytokines in models of neuroinflammation, and can be used in studies of traumatic brain injury, Alzheimer's disease, and alginate toxicity.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number886208-65-7
-
分子量332.4
-
分子式C19H20N6
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESN=1N=C(C(=CC1C=2C=CC=CC2)C)N3CCN(C4=NC=CC=N4)CC3
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
8-Fluoro-6-methoxy M...
8-Fluoro-6-methoxy Moxifloxacin Dihydrochloride
-
Sorbifolin
Sorbifolin 是一种黄酮苷，可以从蝉翼豆 Pterogyne nitens 中分离出来。 Sorbifolin 具有髓过氧化物酶抑制和自由基清除活性。Sorbifolin 也是一种 MPO 抑制剂，IC50 值为 19.2 nM。
-
(D-Arg1,D-Trp7·9,Leu...
Spantide I 是substance P 的类似物，是选择性的神经激肽-1 受体 (NK1 receptor) 的拮抗剂，其对NK1 和 NK2 受体的 Ki 值分别为 230 nM 和 8150 nM。Spantide I 可减少感染角膜的1型细胞因子和增强2型细胞因子 IL-10，从而显著减少角膜穿孔。
